共 18 条
[1]
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: Multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2003, 21 (15)
:2889-2895
[6]
HOLDEN SN, 2005, J CLIN ONCOL S, V23